Furthermore, VEGF-A disruption in an EGF-R-deficient background completely inhibits epidermal tumor growth, suggesting that there is an abnormal contribution of the VEGF-A and the EGF pathways in the tumor cells [17]. This evidence concerns the gene EGF and neoplasm.